A single, open access journal may prevent the primary publishing problems in the life sciences.

Publication peer review publication ethics science communication science funding science policy

Journal

Accountability in research
ISSN: 1545-5815
Titre abrégé: Account Res
Pays: United States
ID NLM: 9100813

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 15 2 2019
medline: 11 7 2020
entrez: 15 2 2019
Statut: ppublish

Résumé

Herein, we discuss a novel way to knit current life sciences publishing structures together under the scope of a single life science journal that would countermand many of the issues faced in current publishing paradigms. Such issues include, but are not limited to, publication fees, subscription fees, impact factor, and publishing in more "glamorous" journals for career health. We envision a process flow involving (i) a single, overall, life sciences journal, (ii) divided into sections headed by learned societies, (iii) to whom all scientific papers are submitted for peer review, and (iv) all accepted scientific literature would be published open access and without author publication fees. With such a structure, journal fees, the merit system of science, and unethical aspects of open access would be reformed for the better. Importantly, such a journal could leverage existing online platforms; that is to say, it is conceptually feasible. We conclude that wholly inclusive publishing paradigms can be possible. A single, open access, online, life sciences journal could solve the myriad problems associated with current publishing paradigms and would be feasible to implement.

Identifiants

pubmed: 30763518
doi: 10.1080/08989621.2019.1582340
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

391-396

Auteurs

Philip Lewis (P)

Institute and Policlinic for Occupational Medicine, Environmental Medicine, and Prevention Research, University Hospital of Cologne , Cologne , Germany.

Constanze Depp (C)

Max Planck Institute for Experimental Medicine , Göttingen , Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH